Article
TGS1 controls snRNA 3’ end processing, prevents neurodegeneration and ameliorates…
medRxiv · 2021 · Chen, L.; Roake, C. M.; Maccallini, P.; Bavasso, F.; Dehghannasiri, R.; Santonicola, P.; Mendoza-Ferreira, N.; Scatolini, L.; Rizzuti, L.; Esposito, A.; Gallotta, I.; Francia, S.; Cacchione, S.; Galati, A.; Palumbo, V.; Tartaglia, G. G.; Colantoni, A.; Proietti, G.; Wu, Y.; Hammerschmidt, M.; De Pitta, C.; Sales, G.; Salzman, J.; Pellizzoni, L.; Wirth, B.; Di Schiavi, E.; Gatti, M.; Artandi, S. E.; Raffa, G. D.
Key facts
| Title | TGS1 controls snRNA 3’ end processing, prevents neurodegeneration and ameliorates SMN-dependent neurological phenotypes in vivo |
|---|---|
| First author | Chen, L.; Roake, C. M.; Maccallini, P.; Bavasso, F.; Dehghannasiri, R.; Santonicola, P.; Mendoza-Ferreira, N.; Scatolini, L.; Rizzuti, L.; Esposito, A.; Gallotta, I.; Francia, S.; Cacchione, S.; Galati, A.; Palumbo, V.; Tartaglia, G. G.; Colantoni, A.; Proietti, G.; Wu, Y.; Hammerschmidt, M.; De Pitta, C.; Sales, G.; Salzman, J.; Pellizzoni, L.; Wirth, B.; Di Schiavi, E.; Gatti, M.; Artandi, S. E.; Raffa, G. D. |
| Journal | medRxiv |
| Published | Nov 27, 2021 |
| DOI | 10.1101/2020.10.27.356782 |
| Devices mentioned | BK110039, K010696, K040782, K073490, K103302 |
| Product codes mentioned | CFN, JAK, JIS, NDS, PCA, JJH, KIT, MVU, NJT, OOI, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1